Trupanion Q2 revenue up 43% to $168.3M; net loss $(9.2)M vs income $1.4M year ago

TRUPANION, INC.

2021-Q2 EPS reported -$0.54 revenue$322,945,000

Total enrolled pets reached 1,024,226 (+38% YoY); subscription enrolled pets 643,395 (+22% YoY).
Subscription revenue $120.4M (+30% YoY); net loss $(0.23) per share vs $0.04 EPS in Q2 2020.
Adjusted EBITDA fell to $0.2M from $5.5M; operating cash flow $(2.2)M vs $4.9M a year ago.
Dr. Zay Satchu appointed as Class I director effective July 30, 2021, joining three committees.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Zay Satchu

Class I Director

TRUP · TRUPANION, INC.

Effective: 2021-07-30
Filed: August 5, 2021, 7:59 PM ET

On July 30, 2021, the board of directors (the “Board”) of Trupanion, Inc. (the “Company”) appointed Dr. Zay Satchu to the Board as a Class I director, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Zay Satchu was appointed as Class I Director at TRUPANION, INC..

Action: appointed
Role: Class I Director

Exact text from the filing

On July 30, 2021, the board of directors (the “Board”) of Trupanion, Inc. (the “Company”) appointed Dr. Zay Satchu to the Board as a Class I director, effective immediately.

View on SEC.gov

TRUPANION, INC. filing history →

Source: SEC EDGAR

accession 0001371285-21-000233

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.